Question 1

What specific types of cancer are eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [177Lu]Lu-AKIR001 First-in-human Study clinical trial (NCT06639191). Contact the study team or your healthcare provider for specific answers.

Question 2

How does [177Lu]Lu-AKIR001 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [177Lu]Lu-AKIR001 First-in-human Study clinical trial (NCT06639191). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [177Lu]Lu-AKIR001 First-in-human Study clinical trial (NCT06639191). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit for treatment and follow-up?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [177Lu]Lu-AKIR001 First-in-human Study clinical trial (NCT06639191). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [177Lu]Lu-AKIR001 First-in-human Study clinical trial (NCT06639191). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [177Lu]Lu-AKIR001 First-in-human Study clinical trial (NCT06639191). Contact the study team or your healthcare provider for specific answers.

What this study is about